Chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II)
- Catalog No.:
- ACYEZB470
- CAS No.:
- 884879-24-7
- Molecular Formula:
- C36H47ClN2Pd
- Molecular Weight:
- 649.64
![Chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) structure diagram](https://xchemchain-prod-1253699568.cos.ap-guangzhou.myqcloud.com/production/attachments/2026/07/22/qe22/884879-24-7.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIDT0SoARehYSEnT2RxQiomY7TcckkZDlIx%2F20261003%2Fap-guangzhou%2Fs3%2Faws4_request&X-Amz-Date=20261003T220843Z&X-Amz-Expires=86400&X-Amz-SignedHeaders=host&response-content-disposition=attachment%3B%20filename%3D%22884879-24-7.png%22&x-id=GetObject&X-Amz-Signature=b11c1911f031f0bca15f24f3d904ae64d337f6712cb0bcefcab750edda7e7791)
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$119.00In stockInquiry
5g98%$593.00In stockInquiry
10g98%$978.00InquiryInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews: View Reviews
Product Information
| Product Name | Chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) |
|---|---|
| IUPAC Name | Chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(II) |
| MDL No. | MFCD09265339 |
| Molecular Formula | C36H47ClN2Pd |
| Molecular Weight | 649.64 |
| SMILES | [Cl-][Pd+4]12(=[C-2]3N(C=4C(=CC=CC4C(C)C)C(C)C)CCN3C=5C(=CC=CC5C(C)C)C(C)C)[CH2]=[CH]2[CH-]1C=6C=CC=CC6 |
| InChI Key | SZCRRCQNRJUVNI-UHFFFAOYSA-M |
| Synonym | 884879-24-7 | MFCD09265339 | Chloro[(1,2,3-h)-3-phenyl-2-propenyl][1,3-bis(2,6-diisopropylphenyl)-4,5-di-H-imidazol-2-ylidene]palladium(II) |
| CAS No. | 884879-24-7 |
| PubChem CID | 155885080 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H315-H319-H335
- Precautionary Statement(s)
- P261-P305+P351+P338